NMM
LGND icon

Naples Money Management’s Ligand Pharmaceuticals LGND Stock Holding History

Naples Money Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$10K Hold
100
– – 0.01% 189
2024
Q2 		$8.48K Buy
+100
New +$7.96K 0.01% 208

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Naples Money Management's LGND Position: Q3 2024 in Review

Naples Money Management held its Ligand Pharmaceuticals (LGND) position steady in Q3 2024 at 100 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #189.

Naples Money Management first reported a position in LGND in Q2 2024 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold LGND as of Q3 2024.

  • Naples Money Management held 100 shares of Ligand Pharmaceuticals worth $10K as of Q3 2024.
  • Naples Money Management left its Ligand Pharmaceuticals share count unchanged in Q3 2024.
  • Ligand Pharmaceuticals made up 0.01% of Naples Money Management's portfolio in Q3 2024, its #189 holding.
  • Naples Money Management first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.